tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ITRM is currently covered by 1 analysts
Iterum Therapeutics PLC's activity chart (see below) currently has 9 price targets and 18 ratings on display. The stock rating distribution of ITRM is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 165 days.
Highest price target for ITRM is $2, Lowest price target is $1.
Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 10-Sep-2024. First documented stock forecast 19-Jun-2018.
Currently out of the existing stock ratings of ITRM, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$5
2 years 5 days ago
(10-Sep-2024)
0/8 (0%)
$3.78 (309.84%)
Buy
$30
$28.87 (2554.87%)
$8
6 years 3 months 13 days ago
(02-Jun-2020)
4/5 (80%)
$5.7 (23.46%)
330
What is ITRM (Iterum Therapeutics PLC) average time for price targets to be met?
Which analyst most recently updated their price target on ITRM (Iterum Therapeutics PLC)?
Which analyst has the current lower performing score on ITRM (Iterum Therapeutics PLC) with a proven track record?
Which analyst has the most public recommendations on ITRM (Iterum Therapeutics PLC)?
Which analyst is the currently most bullish on ITRM (Iterum Therapeutics PLC)?
Which analyst is the currently most reserved on ITRM (Iterum Therapeutics PLC)?
